上皮性卵巢癌中静脉血栓形成与组织因子的评估
本研究为病例对照研究,纳入1995年1月至2013年10月期间在三级医疗中心接受手术的105例卵巢透明细胞癌(OCCC)或高级别浆液性卵巢癌(HGSOC)患者,评估静脉血栓栓塞(VTE)与肿瘤组织因子(TF)表达、血浆TF及微囊泡TF(MV TF)活性的关联。结果发现VTE患者总生存期更差(HR 3.33,CI 1.75-6.35,p<0.0001),但血浆TF及MV TF活性在有无VTE患者间无显著差异;OCCC肿瘤TF表达高于HGSOC(p<0.0001)。结论认为TF MV活性及血浆TF水平不能预测VTE,鉴于OCCC肿瘤广泛表达TF,免疫组化表达不太可能用于该人群VTE风险分层。
要点
- VTE患者总生存期更差,死亡风险增加三倍以上(HR 3.33,CI 1.75-6.35,p<0.0001)。
- 有无VTE患者的中位血浆TF水平及MV TF活性水平无显著差异。
- OCCC患者肿瘤TF表达高于HGSOC患者(p<0.0001)。
核心结论
- TF MV活性及血浆TF水平在该患者人群中不能预测VTE。
- 鉴于OCCC肿瘤广泛表达TF,免疫组化表达不太可能用于该人群VTE风险分层。
研究设计与样本
- 病例对照研究,纳入1995年1月至2013年10月期间在三级医疗中心接受手术的105例OCCC或HGSOC患者。
- 病例组为术后9个月内诊断为VTE的35例OCCC或HGSOC女性。
- 血浆TF采用酶联免疫吸附试验测定,MV TF活性采用TF依赖性因子Xa生成试验测定,肿瘤TF表达采用免疫组化分析评估。
主要发现
- VTE患者总生存期更差,p<0.0001,死亡风险增加三倍以上,HR 3.33(CI 1.75-6.35)。
- 有无VTE患者的中位血浆TF水平无显著差异。
- 有无VTE患者的MV TF活性水平无显著差异。
- OCCC患者肿瘤TF表达高于HGSOC患者,p<0.0001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ovarian clear cell carcinoma (OCCC) and high grade serous ovarian cancer (HGSOC) are associated with the highest risk of VTE among patients with epithelial ovarian cancer (EOC). Tissue factor (TF) is a transmembrane glycoprotein which can trigger thrombosis. We sought to evaluate if there is an association between VTE and tumor expression of tissue factor (TF), plasma TF, and microvesicle TF (MV TF) activity in this high-risk population. METHODS: We performed a case-control study of OCCC and HGSOC patients with and without VTE. 105 patients who underwent surgery at a tertiary care center between January 1995 and October 2013 were included. Plasma TF was measured with an enzyme-linked immunosorbent assay. A TF-dependent Factor Xa generation assay was used to measure MV TF activity. Immunohistochemical (IHC) analysis was performed to evaluate tumor expression of TF. RESULTS: 35 women with OCCC or HGSOC diagnosed with VTE within 9months of surgery were included in the case group. Those with VTE had a worse OS, p<0.0001, with a greater than three-fold increase in risk of death, HR 3.33 (CI 1.75-6.35). There was no significant difference in median plasma TF level or MV TF activity level between patients with and without VTE. OCCC patients had greater expression of TF in their tumors than patients with HGSOC, p<0.0001. CONCLUSIONS: TFMV activity and plasma TF level were not predictive of VTE in this patient population. Given the extensive expression of TF in OCCC tumors, it is unlikely IHC expression will be useful in risk stratification for VTE in this population.
引用
- Cohen JG, Prendergast E, Geddings JE, et al. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer. Gynecol Oncol. 2017. PMID: 28501328. doi:10.1016/j.ygyno.2017.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。